On the heels of a first quarter sales dip, leaders remain confident in Globus Medical’s full-year success, according to a May 8 earnings call. 1. Globus Medical’s Excelsius robotic technologies are ...

Piper Sandler analyst Matt O’Brien lowered the firm’s price target on Globus Medical (GMED) to $80 from $100 and keeps an Overweight rating on the ...

Discover key Q1 2025 insights from Globus Medical, including revenue trends, the Nevro acquisition, free cash flow growth, and future strategies.

Globus Medical now expects adjusted per-share earnings of $3 to $3.30 for the year, down from a prior outlook of $3.10 to $3.40. It backed its full-year sales forecast of $2.8 billion to $2.9 billion.

For the quarter ended March 2025, Globus Medical (GMED) reported revenue of $598.12 million, down 1.4% over the same period last year. EPS came in at $0.68, compared to $0.72 in the year-ago quarter.

Globus Medical expects full-year earnings in the range of $3 to $3.30 per share, with revenue in the range of $2.8 billion to $2.9 billion. This story was generated by Automated Insights ( ...

Trying to climb out of a 2-0 hole, the Celtics could really use the return of their 7-foot-3 unicorn. In today's edition: The "kick change," Draisaitl scores OT winner, Edwards injury scare ...

Conor McMenamin (right) scored St Mirren's second equaliser That could be it for St Johnstone. They are six points adrift at the bottom with just four games to play. Saints took an early lead ...

As you can see from the chart above the percentage of shares that are sold short for Globus Medical has grown since its last report. This does not mean that the stock is going to fall in the near ...

TORONTO - Stewart Johnston plans to ease into his new role as CFL commissioner. Johnston officially took office Thursday following 28 years at TSN. He'd served as the sports broadcaster's ...